Further mechanistic studies identified the role of MDM2 and MDM4 in downregulating p53 expression in MCC cells and found that MDM4, a negative regulator of p53, was upregulated in MCPyV-positive MCC cell lines specifically. This evidence concerns the gene MDM4 and Merkel cell skin cancer.